Improved progression-free and overall survival (PFS/OS) in patients (pts) with emergence of JTX-2011 associated biomarker (ICOS high CD4 T cells) on the ICONIC trial Yap, T., Gainor, J. F., Callahan, M. K., Falchook, G. S., Pachynski, R., LoRusso, P., Kummar, S., Gibney, G., Burris, H. A., Tykodi, S. S., Rahma, O. E., Seiwert, T., Papadopoulos, K. P., Hooper, E., Harvey, C. J., Hanson, A., Lacey, S., McComb, R., Hart, C., Laken, H., McClure, T., Trehu, E. AMER ASSOC CANCER RESEARCH. 2019

View details for DOI 10.1158/1538-7445.AM2019-CT189

View details for Web of Science ID 000488129900168